H 2 O administration results in deuterium labelling of free amino-acids such as alanine and incorporation into proteins of labelled alanine can then be used to measure protein synthesis rates. We examined first if, during 2 H 2 O administration plasma free alanine enrichment is a correct estimate of the enrichment in the tissues aminoacids pools used for protein synthesis. We found that after and peripheral circulation, except for the initial 10 minutes after a loading dose. The kinetics of free alanine labelling were comparable in various tissues (liver, skeletal muscle, heart) and in plasma with identical plateau values. We show next that increased glycolytic rate or absorption of unlabelled aminoacids from ingested meals do not modify alanine labelling. Calculated synthesis rates of mixed proteins were much higher (20 to 70 fold) in plasma and liver than in muscle and heart. Lastly, comparable replacement rates of ApoB100-VLDL were obtained in humans using the kinetics of incorporation into ApoB100 of infused labelled leucine or of alanine labelled by 2 Body proteins are continuously synthesised and degraded. These synthesis and degradation rates are highly variable between individual proteins and are modified by physiological factors and pathological situations. Since maintain of adequate amounts of whole body protein store but also of a given protein in plasma or tissue is essential for health, much effort has been devoted to the measurement of protein synthesis rate, particularly in humans and several approaches have been proposed (26, 28) . Most measure protein synthesis using the precursor-product method, i.e. by following the incorporation into proteins of a labelled amino-acid after acute (bolus) or prolonged (infusion) administration of this labelled molecule. A central problem in this method is to correctly measure the enrichment in the true precursor pool, the tRNA-bound amino-acid for protein synthesis. Enrichment of the precursor by the tracer administered is usually measured in the plasma, the only pool that can be easily sampled, particularly in humans since ethical considerations limit access to tissues. Assuming that enrichment of in the plasma amino-acid pool reflects enrichment in the true precursor pool is questionable. It has been proposed that measuring the enrichment of plasma -ketoisocaproate during the infusion of labelled leucine (21) , or of urinary hippurate during the infusion of labelled glycine (8) , would give a correct estimate of the enrichment in the true precursor pool. Alternatively, one can give a large bolus of a labelled amino-acid since, by flooding the system with a large amount of amino-acid, the labelling in plasma and in the intra-cellular pools should be comparable (13) . However, these methods have been questioned (22) . Lastly, one possibility is to administer the labelled aminoacid continuously during several half-lives of the protein investigated; the label in the protein will eventually reach a plateau equal to the enrichment of the precursor pool. However, since the labelled amino-acid is usually given intravenously in order to obtain stable enrichment level in the precursor pool, this approach to measure the enrichment in the precursor pool can be reasonably used only for proteins with short half-life.
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Deuterated water is now used for measuring several aspects of glucose and lipid metabolism (2, 5, 7, 10, 12, 14, 16, 18, 23, 24) . Its use for estimating protein synthesis, initially proposed by Ussing (25) , has been recently revived and developed (2, 6, 11, 19 ). The basis is that, after administration of deuterated water, 2 H atoms distribute rapidly in whole body water and label free amino-acids through various enzymatic reactions. Transamination in particular will label all free amino-acids, including essential ones, at their carbon (17). Labelled amino-acids are then incorporated into protein during their synthesis. 2 H 2 O is an attractive tracer that offers important advantages. First, it can be given orally, making studies in humans and animals much easier than with tracers needing intra-venous infusion. Second, it is a safe, relatively inexpensive tracer that can be administered during long periods (up to several weeks), with stable enrichment levels in plasma water (12) , making it appropriated for studying molecules with slow turnover rate. In principle the incorporation of any amino-acid into proteins could be used for measuring protein synthesis. In practice, alanine is attractive and convenient since it has four possible sites of incorporation of deuterium (17); this results in a much higher enrichment level (up to four times) in free alanine than in body water, increasing the sensitivity and the accuracy of the measurements of enrichments in newly synthesised protein in the presence of safe enrichment levels in water. The usefulness of this method for measuring proteins synthesis rate in vivo in animals and in humans has been recently demonstrated (2, 6, 11, 19) . This method needs, as other precursor-product methods, determination of the enrichment in the precursor pool. This can be achieved by measuring enrichment in plasma water, provided that N, the number of effective incorporation sites of deuterium in the chosen free amino-acid, is known. Multiplying enrichment in plasma water by N gives the enrichment in the precursor pool. N can be determined by the mass isotopomer distribution analysis of the labelled amino-acid incorporated into the protein studied (6) . However this needs relatively high enrichment levels in body water in order to have reliable measurements of enrichment for the m+2 isotopomer. One can use for Page 4 of 34 the calculation previously published N values, assuming that this value is constant, whatever the protein studied, the tissue synthesising it and the situation investigated. This assumption is supported for alanine by the results of Bush et al (6) but will need further examination. A more direct possibility is to measure the enrichment of the free amino-acid in plasma. Labelling by deuterium occurs during intra-cellular enzymatic reactions and the only source of label in plasma is intra-cellularly labelled amino-acid. Therefore enrichment in plasma should reflect enrichment in tissues. However this will be true if i) intra-tissular enrichment is homogenous, i.e. if reactions resulting in deuterium labelling proceed in all tissues at a rate high enough compared to endogenous supply of unlabelled alanine, through for example proteolysis, to prevent any dilution of the label in a tissue compared to another one, ii) exchanges rates between the tissular and plasma pools of alanine are sufficiently high to allow rapid equilibration even in situations of entry of unlabelled alanine (for example after ingestion of a protein meal). Therefore a first aim of the present study was to compare during To our knowledge, no comparison between portal and peripheral plasma enrichments has been performed. Therefore a second aim was to compare in rats enrichments of water and alanine in 
Materials and methods

Chemicals and supplies
Rats experiments :
All experiments were performed in accordance with the Guiding Principles in the care and Use of animals.
Comparison of deuterium enrichments in portal and peripheral plasma water and alanine after bolus oral administration of 2 H 2 O.
In these experiments male Wistar rats were given at 09h am, in the fed state, a loading dose of In a first serie of experiments 18 male Wistar rats received between 08 and 09h am a loading dose of 2 H 2 O (intra-peritoneal injection, 10ml/kg, isotonic with NaCl). They had then free access to drinking water enriched (3%) with 2 H 2 O. All these rats had their food removed at 06h p.m. the previous day. 9 rats were kept fasting during the experiment (fasted group) and the other nine rats had free access to food after the bolus injection of 
Studies in humans:
All subjects gave their written informed consent after full explanation of the purpose, nature and risks of the studies. Protocols were approved by a local Ethical Committee.
In a first study 10 healthy control subjects ( Plasma glucose and insulin concentrations were measured in humans by enzymatic method and radioimmunoassay respectively (4)
H labelling :
2 H enrichment (isotopic enrichment, IE) in plasma water was determined as previously described (27) . For the enrichment of free alanine in plasma, plasma was deproteinized by perchloric acid (6%) and after centrifugation the supernatant was neutralized by K 2 CO 3 (3M). After acidification (pH = 2) by 1N HCl, this supernatant was applied to a cathion exchange column (AGWX4, hydrogen form). The column was washed with water and amino-acids were then eluted with 4N NH 3 OH. The eluate was dried before preparation of the t-butyldimethylsilyl derivative of alanine (20) . One µl was injected into a gas chromatograph (HP5890, Hewlett-Packard, Palo Alto, CA) equipped with a 25-m fused silica capillary column (OV1701, Chrompack, Bridgewater, NJ) and interfaced with a HP5971A mass spectrometer (Hewlett-Packard) working in the electron impact mode. Carrier gas was helium. Operating conditions were: injector 240°C, split ratio 1/10, oven 80°C during 4 minutes, rising then at 20°C/min until 250°C with a final plateau of 5 min.
Alanine elutes at ~ 10 min. Ions of m/z 260 and 261 were collected and enrichment calculated from standards run along with the samples. For measuring free alanine enrichment in tissues, 100-200 mg of tissue were homogenised in 1 ml of perchloric acid (6%) and the supernatant was used for purification and preparation of the derivative of free alanine as described for plasma. For the alanine of plasma or tissue proteins, proteins were precipitated by perchloric acid and after centrifugation the precipitate was washed thrice with water before hydrolysis of proteins by 6N HCl (15 hours at 100°C). The hydrolysate was diluted to 0.6 N HCl before purification of alanine as described above. In some experiments in humans, deuterium labelling was also measured in plasma glucose and lactate. These molecules were purified from neutralized perchloric acid extracts of plasma by ion-exchange chromatography (3, 15) before preparation of Page 9 of 34 the bisbutylboronateacetyl derivative of glucose (4) and t-butyldimethylsilyl derivative of lactate (20) For measurement of enrichment of ApoB100-VLDL by trideuterated leucine and by deuterated alanine, plasma VLDL were first purified by ultracentrifugation and apoB100 was separated of other proteins by polyacrylamine gel electrophoresis (9) . Purified apoB100 was then hydrolysed as described above. Purification of alanine and leucine and preparation of their tbutyldimethylsilyl derivatives were performed as described above. 
RESULTS
Experiments in rats
Comparison of plasma water and alanine IE in portal and peripheral circulation after bolus oral administration of 2 
H 2 O (figure 1)
As in previous studies (11) stable IE in both plasma water and alanine were obtained at 20 min in peripheral plasma with a ratio of total alanine over water enrichment of 3.7-4.0. These IE were comparable in portal and peripheral circulation at 20, 30 and 45 minutes. However, at 10 minutes, plasma water and alanine IE were moderately higher (p<0.05) in portal than in peripheral plasma. These values in peripheral plasma were also slightly lower from those observed at plateau (20-45 min).
Kinetics of IE in plasma and tissues during administration of 2 H 2 O :
-Kinetics of labelling in plasma water and alanine : Stable IE were obtained for water between 2 and 8 hours after the initial bolus administration of 2 H 2 O, in both portal and peripheral plasma (Table 1 ). There was a slight increase (0.2-0.4%) in alanine labelling between 2 and 8 hours but this increase represented less than 8% of the value observed at 8 hours. Total alanine over water enrichment ratios were 3.8-4.2. Values in portal and peripheral plasma were identical and comparable results were obtained in fasted and fed rats (Table 1 ). In fed rats deuterium enrichment in plasma water and free alanine were also measured in peripheral plasma at 24 and 80 hours (figure 2); values were identical to those observed from 2 to 8 hours. Therefore reasonable plateau values of labelling for both plasma water and alanine are quickly obtained and maintained in rats, without difference between portal and peripheral plasma except for the initial 10 minutes after bolus administration of 
Kinetics of labelling in protein-bound alanine (figures 4-6)
The increase of labelling was as expected slower than for free alanine but near plateau values were obtained at 80h for mixed plasma and liver proteins and the experimental points could be 
Studies in humans :
In the first protocol we measured deuterium enrichments in plasma water and free alanine during a 12h period of administration of deuterated water. In fasting subjects plateau values were obtained from 1 to 12 hour (figure 7) for both water and alanine with an alanine over water enrichment ratio around 3.8. Stable enrichment in plasma lactate was also obtained, with a lactate over water enrichment ratio around 2.8 (data not shown). When subjects ingested glucose during the test, no significant decrease of enrichment in alanine (figure 7) or lactate (data not shown) was observed and the enrichment ratios of alanine over water were unchanged.
In the second experiment we measured labelling in plasma water, total alanine, lactate and glucose in subjects consuming their usual diet. Stable enrichment level around 0.35% was obtained in plasma water throughout the whole study period. As shown in figure 8 enrichment in Page 13 of 34 glucose was lower in the post-prandial state than in the post-absorptive state, reflecting as expected the dilution of endogenously produced, and labelled, glucose by exogenous, unlabeled glucose. However enrichments in lactate and alanine were identical in the post-prandial and the post-absorptive states. Therefore, feeding did not modify alanine labelling and plateau values were observed throughout the whole experimental period.
In the last study we compared the kinetics of labelling of ApoB100-VLDL by trideuterated leucine (infusion of [5, 5, H 3 ]-leucine) and deuterated alanine (ingestion of deuterated water).
Deuterated water induced only a slight increase in the m+1 (around 0.3%) of plasma leucine. The increase in the m+1 of leucine in ApoB100-VLDL was less than 0.3% and not sufficient to induce any significant increase in the m+3 of leucine. The final values of enrichments of alanine and leucine in ApoB100VLDL were respectively near to the enrichments of plasma alanine and -KIC ( figure 9 ). The rises of enrichment in leucine and alanine of ApoB100-VLDL ( figure 9) were fitted to a single exponential rise. k values calculated using leucine or alanine enrichment kinetics were comparable (0.157/h vs. 0.139/h respectively).
DISCUSSION
The use of deuterated water to measure synthetic pathways (7, 10, 16, 24) has recently been extended to the determination of protein synthesis rates (6, 11, 19) . We examined in the present report some aspects of this use of deuterated water to investigate protein metabolism. We show i) that there is during The oral ingestion or IP injection of 2 H 2 O could result in a higher labelling of plasma water, and possibly of free alanine, in portal than in peripheral circulation. We checked therefore whether such a gradient in enrichment existed or if a rapid isotopic equilibrium between portal and peripheral plasma was obtained. We found indeed that 10 minutes after an oral bolus administration of 2 H 2 O in rats, plasma water and alanine enrichments were moderately higher in portal than in peripheral circulation. However this difference was transient since identical enrichment values in portal and peripheral plasma were attained for both water and alanine as early as 20 min after the bolus. In addition, stable enrichment levels were obtained in peripheral, confirming the results of Dufner et al (11) , and portal plasma. When deuterated water was given in rats by IP injection followed by ad libitum drinking of water, stable labelling with identical values in portal and peripheral plasma were obtained in the following hours for both water and alanine. Therefore, except for the initial minutes after a loading dose of 2 H 2 O, peripheral enrichments are representative of the portal ones. There is no gradient of enrichment between portal and peripheral circulation that would bear on the measurement of synthesis rates of protein synthesised and secreted by the liver by the deuterated water method. We could not perform such direct comparison of portal and peripheral enrichments during 2 H 2 O administration in humans but it is highly probable that there is also no enrichment gradient. This is supported by the direct comparison in the same subjects of the kinetics of labelling of ApoB100-VLDL by intravenously infused labelled leucine and by alanine deuterated by orally ingested water. From a more general point of view, the finding of comparable turnover rates of ApoB100-VLDL when using for the calculation the labelling by one tracer or the other strongly supports the validity of the use of deuterated water.
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Dufner et al (11) showed that the IV bolus injection of unlabeled alanine in rats having received deuterated water induced a transient decrease in plasma alanine enrichment despite stable labelling in water. However the quantity of alanine injected was largely supraphysiological. We examined whether a physiological entry of unlabeled alanine through intestinal absorption after a meal would modify plasma alanine enrichment. In rats we observed no difference in peripheral or portal plasma alanine enrichment, nor in tissues free alanine enrichment, between the fasted and the fed state In humans, we observed also no decrease in plasma alanine, nor in lactate, enrichment after meals, despite the clear and expected decrease in total glucose labelling. We found also in humans no decrease in plasma alanine labelling when glycolytic rates were increased by the oral ingestion of glucose. These results show that stable enrichment levels of plasma alanine by deuterated water are indeed maintained in everyday life despite the alternation of feeding and fasting. This further supports the use of deuterated water for long term studies with measurement of the kinetics of proteins with slow turnover rates.
A main aim was to determine whether during deuterated water administration free alanine enrichment by deuterium in tissues is homogenous and if plasma alanine enrichment can be used as a correct estimate of tissular enrichment for the determination of protein kinetics. We found that the kinetics of free alanine labelling in liver, skeletal muscle and heart are identical, with near to plateau values at 2 hour and identical plateau values. Moreover these kinetics are comparable to the one of free alanine labelling in plasma. When comparing the initial (until 8 hours) values obtained in tissues in rats studied in the fed or fasted state, we observed again no differences. Therefore tissue labelling appears homogenous and, although an absolute demonstration would have needed comparison with the enrichment in t-RNA-alanine, our results support the use of plasma free alanine enrichment as a substitute for the intra-tissular precursor pool enrichment. This is further supported by our finding that the calculated plateau values Page 16 of 34 obtained by fitting experimental points of the labelling of proteins bound alanine were comparable to the plateau values of free alanine measured in tissues and plasma. This comparison could be performed only for mixed liver and plasma proteins. The increase of labelling in alanine of mixed proteins from muscle and heart was too slow to allow such calculation. It is noteworthy that the replacement rates of proteins in these tissues estimated by linear fitting of the rise in alanine enrichment are comparable to the values reported by Bush et al when using non-linear curve fitting (6) . This strongly suggests that, when experimental conditions do not allow to collect enough data to perform non-linear curve fitting, the initial, near linear, part of the rise of enrichment in protein bound alanine can be used to correctly estimate protein dynamics. It should be stressed that what is truly measured by the approach we used in the present report, modeling of the rise of enrichment in proteins, is protein fractional synthetic rate. This synthetic rate is equal to replacement rate only if the pool of protein investigated is stable. However, when this pool is changing, 2 H 2 O can be used to determine fractional synthetic rate and also fractional degradation rate by modeling the increase and decrease of labeling during 2 H 2 O administration and after its interruption (2, 19 ).
In conclusion the present results strongly support the use for determination of protein kinetics during deuterated water administration of enrichment of free alanine in peripheral plasma as a substitute for the enrichment in tissue precursor pool. They lend further support to the use of deuterated water as a safe, convenient, reliable and attractive way for investigating protein metabolism in vivo. ).
Figure 3:
Deuterium enrichment of free alanine in tissues (liver, skeletal muscle and heart (left ventricle)) measured in rats during 80 h after an IP bolus injection of deuterated water followed by ad libitum drinking of water enriched with deuterated water. Results are shown as mean and sem.
The curves shown were obtained by fitting the experimental points to a single exponential rise to plateau. Deuterium enrichment of the alanine of mixed proteins of skeletal muscle and heart in rats 8, 24
and 80 h after an IP bolus injection of deuterated water followed by ad libitum drinking of water enriched with deuterated water. Results are shown as mean and sem. 
